Clinical Trials Directory

Trials / Completed

CompletedNCT00490048

Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Ulcerative colitis is a systemic disease we assume that extra intestinal involvement as we describein our study( Fireman Z, Osipov A, Kivity S, Kopelman Y, Sternberg A Fireman E: Assessment of pulmonary involvement in Crohn's disease by induced sputum. Am J Gastroenterol 2000;95(30):730-734. )

Detailed description

Twenty Ulcerative colitis patients and 20 control subjects (all nonsmokers) without respiratory symptoms will be tested. The induce sputum by 20' inhalation of 3.5% saline using ultrasonic nebulizer. Samples will studied by differential counts of 200 cells on cytopreps stained by Giemsa. T-lymphocyte subset analyses were done by FACS using three monoclonal antibodies: CD3 = total T cells, CD4 = T helper cells, and CD8 = T suppressor-cytotoxic cells. CD4/CD8 \>2.5 was considered abnormal.

Conditions

Interventions

TypeNameDescription
PROCEDUREInduced sputum (inhalation of 3.5% saline)

Timeline

Start date
2007-06-01
Completion
2007-06-01
First posted
2007-06-22
Last updated
2007-06-22

Source: ClinicalTrials.gov record NCT00490048. Inclusion in this directory is not an endorsement.